The Good The Bad And The Non-Quantifiable – A Comparison of Rebates on Orphan Drugs Versus Non-Orphan Drugs In Germany
Abstract
Authors
T Wijnands M Schuchardt T Nijhuis
T Wijnands M Schuchardt T Nijhuis
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now